926results about How to "Effective penetration" patented technology

The present invention is directed to controlling pest infestation by inhibiting one or more biological functions in an invertebrate pest. The invention discloses methods and compositions for use in controlling pest infestation by feeding one or more different recombinant double stranded RNA molecules to the pest in order to achieve a reduction in pest infestation through suppression of gene expression. The invention is also directed to methods for making transgenic plants that express the double stranded RNA molecules, and to particular combinations of transgenic pesticidal agents for use in protecting plants from pest infestation.

The present invention relates to control of pest infestation by inhibiting one or more biological functions. The invention provides methods and compositions for such control. By feeding one or more recombinant double stranded RNA molecules provided by the invention to the pest, a reduction in pest infestation is obtained through suppression of gene expression. The invention is also directed to methods for making transgenic plants that express the double stranded RNA molecules, and to particular combinations of transgenic pesticidal agents for use in protecting plants from pest infestation.

The present invention provides nucleoside aryl phosphoramidates which are precursors to inhibitors of RNA-dependent RNA viral polymerase. These compounds are precursors to inhibitors of RNA-dependent RNA viral replication and are useful for the treatment of RNA-dependent RNA viral infection. They are particularly useful as precursors to inhibitors of hepatitis C virus (HCV) NS5B polymerase, as precursors to inhibitors of HCV replication, and/or for the treatment of hepatitis C infection. The invention also describes pharmaceutical compositions containing such nucleoside aryl phosphoramidates alone or in combination with other agents active against RNA-dependent RNA viral infection, in particular HCV infection. Also disclosed are methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and/or treating RNA-dependent RNA viral infection with the nucleoside aryl phosphoramidates of the present invention.

Sprayable, anhydrous and physically/chemically stable dermatological/pharmaceutical compositions, well suited for the treatment of a variety of dermatological disorders, notably psoriasis, contain: a) a therapeutically effective amount of a solubilized corticoid, notably dissolved clobetasol propionate; b) a therapeutically effective amount of a solubilized vitamin D derivative, notably dissolved calcitriol; and c) an oily phase which comprises one or more oils; formulated into d), a sprayable and topically applicable, dermatologically/pharmaceutically acceptable vehicle therefor.

The present invention provides nucleoside aryl phosphoramidates of structural formula (I) which are precursors to inhibitors of RNA-dependent RNA viral polymerase. These compounds are precursors to inhibitors of RNA-dependent RNA viral replication and are useful for the treatment of RNA-dependent RNA viral infection. They are particularly useful as precursors to inhibitors of hepatitis C virus (HCV) NS5B polymerase, as precursors to inhibitors of HCV replication, and/or for the treatment of hepatitis C infection. The invention also describes pharmaceutical compositions containing such nucleoside aryl phosphoramidates alone or in combination with other agents active against RNA-dependent RNA viral infection, in particular HCV infection. Also disclosed are methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and/or treating RNA-dependent RNA viral infection with the nucleoside aryl phosphoramidates of the present invention.

A method and apparatus for puncturing a surface for extraction, in situ monitoring, and/or substance delivery uses microneedles with improved properties. Applications include easy to handle glucose monitoring using a group of hollow out-of-plane silicon microneedles to sample substances in interstitial fluid from the epidermal skin layer.

A device includes a plurality of microneedles for abrading the stratum corneum of the skin to form a plurality of grooves in the tissue having a controlled depth and width. The microneedles have a length of about 5-250 microns and generally about 5-200 microns. The device is rubbed over the skin to prepare an abraded site after which a transdermal delivery or sampling device is applied to the abraded delivery site. The abrasion increases the permeability of the skin and the rate of delivery and extraction of a substance without pain or irritation to the patient.

An Implantable Pulse Generator (IPG) includes a surgically implantable housing, a battery, a first waveform generator, a second waveform generator, a modulator, and electrodes. The IPG produces a pulse envelope, a carrier waveform, and a modulated waveform. The pulse envelope is a low frequency waveform with specific pulse width, amplitude and shape to selectively stimulate a target nerve or body part. The carrier waveform is a high frequency waveform with properties such as amplitude, frequency and the like chosen so as to overcome tissue impedance and the stimulation threshold of the target nerve. The modulated waveform is the waveform obtained by modulating the carrier waveform by the pulse envelope.

The present invention provides nucleoside cyclic phosphoramidates of structural formula (I) which are precursors to inhibitors of RNA-dependent RNA viral polymerase. These compounds are precursors to inhibitors of RNA-dependent RNA viral replication and are useful for the treatment of RNA-dependent RNA viral infection. They are particularly useful as pre-cursors to inhibitors of hepatitis C virus (HCV) NS5B polymerase, as precursors to inhibitors of HCV replication, and/or for the treatment of hepatitis C infection. The invention also describes pharmaceutical compositions containing such nucleoside cyclic phosphoramidates alone or in combination with other agents active against RNA-dependent RNA viral infection, in particular HCV infection. Also disclosed are methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and/or treating RNA-dependent RNA viral infection with the nucleoside cyclic phosphoramidates of the present invention.

Soluble fibrous structures and more particularly soluble fibrous structures that contain one or more fibrous elements, such as filaments, having one or more fibrous element-forming materials and one or more active agents present within the fibrous elements, wherein the fibrous structure exhibits improved dissolution properties compared to known soluble fibrous structures, and method for making such improved fibrous structures are provided.

The invention discloses a micro-polarizing film array used for acquiring full-polarization parameters and a production method and application thereof. The micro-polarizing film comprises a plurality of micro-polarizing film units with size of 2*2. Each micro-polarizing film unit comprises a micro-polarizing film of 0 degree, a micro-polarizing film of 45 degrees, a circular micro-polarizing film and a micro-polarizing film of 90 degrees which are closely integrated on the same plane and further sequentially disposed from the top left corner in a clockwise manner. The micro-polarizing film array is easy to produce and high in polarizing light transmittance performance and integration level.

The invention discloses lead-free glass powder, a preparation method thereof, silver paste containing the glass powder and a crystal silicon solar cell manufactured by using the silver paste. The lead-free glass powder comprises the following components in percentage by weight: 20-30 percent of SiO2, 2-15 percent of B2O3, 40-70 percent of Bi2O3, 1-10 percent of ZnO, 1-10 percent of Al2O3 and 1-5 percent of BaO. The preparation method comprises the following steps of: (1) weighing the components for preparing a mixture; (2) putting the mixture into a crucible for melting; (3) performing water quenching on molten glass; (4) drying; (5) smashing the mixture into powder by planetary ball milling; and (6) screening. The needed silver paste is prepared from the lead-free glass powder, silver powder, an additive and an organic carrier. A solar panel front face electrode and a grid line are manufactured by performing screen printing and sintering on conductive silver paste on a cell substrate, so that the needed solar cell is obtained. The lead-free glass powder has low melting temperature, low softening temperature and low linear expansion factor.

A Chinese medicine for treating osteophyte, rheumatic or rheumatoid arthritis, osteoarthritis, ischias, lumbar intervertebral disc protrusion, periomethritis, etc includes the enterior-applied pills prepared from 46 Chinese-medicinal materials and the exterior-applied ointment prepared from 54 Chinese-medicinal materials.

A method and apparatus for effective through-the-earth communication involves a signal input device connected to a transmitter operating at a predetermined frequency sufficiently low to effectively penetrate useful distances through-the earth, and having an analog to digital converter receiving the signal input and passing the signal input to a data compression circuit that is connected to an encoding processor, the encoding processor output being provided to a digital to analog converter. An amplifier receives the analog output from the digital to analog converter for amplifying said analog output and outputting said analog output to an antenna. A receiver having an antenna receives the analog output passes the analog signal to a band pass filter whose output is connected to an analog to digital converter that provides a digital signal to a decoding processor whose output is connected to an data decompressor, the data decompressor providing a decompressed digital signal to a digital to analog converter. An audio output device receives the analog output form the digital to analog converter for producing audible output.

A gas pressure-reducing valve includes a pressure-reducing chamber for generating a gas pressure that acts on one surface of a diaphragm, a valve body that can sit on a valve seat having in its central part a valve hole communicating with the pressure-reducing chamber, and a spring biasing the diaphragm in a direction that detaches the valve body from the valve seat. A valve housing is formed by conjoining a body, a partition, and a cover. The partition forms the pressure-reducing chamber between itself and the body and forms a pressure action chamber between itself and the diaphragm. The cover forms the spring chamber between itself and the other surface of the diaphragm and has the peripheral edge of the diaphragm clamped between itself and the partition. The partition has a through hole for allowing the valve stem to run through in an airtight and axially slidable manner and a communicating hole for providing communication between the pressure action chamber and the pressure-reducing chamber. The structure of the body can thus be simplified thereby enhancing the machining precision, and the diameter of the pressure-reducing chamber can be determined regardless of the diameter of the diaphragm.